OXcarbazepine 150 mg 24HR Extended Release Oral Tablet
RxNorm 1365653
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1365653 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: OXcarbazepine 150 mg 24HR Extended Release Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
24 HR oxcarbazepine 150 mg Extended Release Oral Tablet
(Atom ID: 6351789)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
24 HR OXcarbazepine 150 mg Extended Release Oral Tablet
(Atom ID: 6377700)
SYPrescribable
Synonym (SY):
Oxcarbazepine 150 mg 24 HR Extended Release Oral Tablet
(Atom ID: 6357015)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
OXcarbazepine 150 mg 24 HR Extended Release Oral Tablet
(Atom ID: 6376258)
PSNPrescribable
Prescribable Name (PSN):
OXcarbazepine 150 mg 24HR Extended Release Oral Tablet
(Atom ID: 6365755)
Patient Education
Oxcarbazepine
Oxcarbazepine (Trileptal) is used alone or in combination with other medications to control certain types of seizures in adults and children. Oxcarbazepine extended-release tablets (Oxtellar XR) are used in combination with other medications to control certain types of seizures in adults and children 6 years of age and older. Oxcarbazepine is in a class of medications called anticonvulsants. It works by decreasing abnormal electrical activity in the brain.
[Learn More]
* Please review the disclaimer below.